Candida peritonitis: Prevalence and risk factors;Candidiasis peritoneal: Prevalencia y factores de riesgo

Revista Iberoamericana de Micologia

Volumn 30, Issue 3, 2013, Pages 189-192

  Hernández, María José ^a   Balaguer, Josep ^a   Armero, Rocío ^a   Baldó, Joana ^a   Gómez, Lorena ^a   Solaz, Cristina ^a  

^a HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

Invasive candidiasis; Peritoneal candidiasis; Peritoneal fluid

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; HEART FAILURE; HOSPITAL INFECTION; HUMAN; PERITONEAL CANDIDIASIS; PERITONEAL FLUID; PERITONITIS; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; UPPER GASTROINTESTINAL TRACT; ADULT; AGED; ASCITES FLUID; BIOLOGICAL MODEL; CANDIDA; CANDIDIASIS, INVASIVE; CROSS INFECTION; FEMALE; INTRAOPERATIVE COMPLICATIONS; ISOLATION AND PURIFICATION; LAPAROTOMY; MALE; MICROBIOLOGY; MIDDLE AGED; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SEX RATIO; SPAIN; STATISTICS AND NUMERICAL DATA; SUPERINFECTION; UNIVERSITY HOSPITAL;

CANDIDA; CANDIDA ALBICANS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; ASCITIC FLUID; CANDIDA; CANDIDIASIS, INVASIVE; CROSS INFECTION; FEMALE; HEART FAILURE; HOSPITALS, UNIVERSITY; HUMANS; INTRAOPERATIVE COMPLICATIONS; LAPAROTOMY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PERITONITIS; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION; SPAIN; SUPERINFECTION;

EID: 84886952814     PISSN: 11301406     EISSN: 21739188     Source Type: Journal    
DOI: 10.1016/j.riam.2012.10.005     Document Type: Article

References (19)

1. Aguado J.M., Ruiz-Camps I., Muñoz P., Mensa J., Almirante B., Vázquez L., et al. Recomendaciones sobre el tratamiento de la candidiasis invasiva y otras infecciones por levaduras de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2011. Enferm Infecc Microbiol Clin 2011, 29:345-361.
2. Ayats J., Martín E., Pemán J., Quindós G., Sánchez F., García J., et al. Recomendaciones sobre el diagnóstico de la enfermedad fúngica invasora de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2010. Enferm Infecc Microbiol Clin 2011, 29:39. e1-15.
3. Barthlen W., Bartels H., Busch R., Siewert J.R. Prognostic factors in diffuse peritonitis. Langenbecks Arch Chir 1992, 377:89-93.
4. Bayer A.S., Blumenkrantz M.J., Montgomerie J.Z., Galpin J.E., Coburn J.W., Guze L.B. Candida peritonitis. Report of 22 cases and review of the English literature. Am J Med 1976, 61:832-840.
5. Blot S.I., Vanderwoude K.H., de Waele J.J. Candida peritonitis. Curr Opin Crit Care 2007, 13:195-199.
6. Dupont H., Bourichon A., Paugam C., Mantz J., Desmonts J.M. Can yeast isolation in peritoneal fluid be predictive in intensive care unit patients with peritonitis?. Crit Care Med 2003, 31:752-756.
7. Garnacho J., León C. Resumen de las recomendaciones terapéuticas para infecciones fúngicas en el paciente crítico no neutropénico: una visión multidisciplinar. Farm Hosp 2005, 29:283-289.
8. Guirao X., Arias J., Badía J.M., García J.A., Mensa J., Álvarez F., et al. Recomendaciones en el tratamiento antibiótico empírico de la infección intraabdominal. Rev Esp Quimioter 2009, 22:151-172.
9. Hsu F.C., Lin P.C., Chi C.Y., Ho M.W., Ho C.M., Wang J.H. Prognostic factors for patients with culture-positive Candida infection undergoing abdominal surgery. J Microbiol Immunol Infect 2009, 42:378-384.
10. León C., Ruiz S., Saavedra P., Galván B., Blanco A., Castro C., et al. Diferenciación entre candidiasis invasiva y colonización por Candida: "Candida score". REMI 2009, 9:1364.
11. Leroy O., Gangneux J.P., Montravers P., Mira J.P., Gouin F., Sollet J.P., et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observacional study in France (2005-2006). Cri Care Med 2009, 37:1612-1618.
12. Magill S.S., Swoboda S.M., Shields C.E., Colantuoni E.A., Fothergill A.W., Merz W.G., et al. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: Follow-up to a randomized clinical trial. Ann Surg 2009, 249:657-665.
13. Montravers P., Dupont H., Gauzit R., Veber B., Auboyer C., Blin P., et al. Candida as a risk factor for mortality in peritonitis. Crit Care Med 2006, 34:646-652.
14. Montravers P., Mira J.P., Gangneux J.P., Leroy O., Lortholary O. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect 2011, 17:1061-1067. AmarCand study group.
15. Nolla J., Sitges A., León C., Martínez J., León M.A., Ibáñez P., et al. Candidemia in non-neutropenic critically ill patients: Analysis of prognostic factors and assessment of systemic antifungal therapy. Intensive Care Med 1997, 23:23-30.
16. Ostrosky-Zeichner L., Pappas P. Invasive candidiasis in the intensive care unit. Crit Care Med 2006, 34:857-863.
17. Pappas P., Kauffman C., Andes D., Benjamin D., Calandra T., Edwards J., et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 48:503-535.
18. Tactic M., Stanic D., Draskovic B., Komarcevic A., Gajdobranski D. Role and importance of fungal infections in intensive care units. Med Pregl 2003, 56:537-541.
19. Zaragoza R., Pemán J., Salavert M. ¿Implica el aislamiento de Candida spp. en muestras intraabdominales de pacientes críticos la necesidad de tratamiento antifúngico?. Rev Iberoam Micol 2008, 25:203-207.